American Urological Association Annual Meeting--AUA 2004. 8-13 May 2004, San Francisco, CA, USA.
Significant areas of new drug development discussed at this year's American Urological Association (AUA) meeting included: antioxidants, immunosuppressants, anti-androgens, kinase inhibitors, immunotherapeutic agents and antitumor vaccines. The poster and podium sessions devoted to urologic neoplasia concentrated on novel drug and vaccine development.
Jamison
James
J
Northeastern Ohio Universities College of Medicine, 4209 Street, Route 44, PO Box 95, Rootstown, OH 44272-0095, USA. jmj@neoucom.edu
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents